Is there a role for urinary podocyte excretion assessment in lupus nephritis?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.3109/0886022X.2016.1150099 https://repositorio.unifesp.br/handle/11600/56047 |
Resumo: | Objective To establish the occurrence and intensity of podocyturia and its relation to grade of disease activity, as defined by clinical and laboratory criteria. Methods Prospective, cross-sectional study involving 50 patients with lupus nephritis and 29 controls, which had podocyturia levels determined from random urine samples using an immunofluorescence technique. Disease activity was graded by BILAG (renal criteria) and an additional system used in the service (S2). Results Fifty patients with lupus nephritis (WHO classes III, IV and V), with a median age of 37years, were evaluated. Of these, 86.5% were female, and 52% were BILAG A. Podocyturia quantification in the lupus nephritis and control groups differed significantly (p = 0.009). This score was higher in relation to classes III, IV and V. The correlation with C3 consumption was stronger (p = 0.011) than with C4. The highest levels were found in the most active groups (A and B of BILAG and S2). Lower podocyturia correlated with a lower dose of prednisone. There was no association with the intensity of proteinuria, hematuria or pyuria, serum creatinine levels, among others. Conclusions Podocyturia assessment, which was performed by immunofluorescence in this study, can be used as an indicator of disease activity with the advantage of being a urinary biomarker. The levels proved to be higher in patients with lupus nephritis than in the controls and were particularly higher in class IV. |
id |
UFSP_b4cd4ce184a33e4f13448cf2348a13aa |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/56047 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Is there a role for urinary podocyte excretion assessment in lupus nephritis?Glomerulonephritissystemic lupus erythematosuslupus nephritispodocyturiapodocytesproteinuriaObjective To establish the occurrence and intensity of podocyturia and its relation to grade of disease activity, as defined by clinical and laboratory criteria. Methods Prospective, cross-sectional study involving 50 patients with lupus nephritis and 29 controls, which had podocyturia levels determined from random urine samples using an immunofluorescence technique. Disease activity was graded by BILAG (renal criteria) and an additional system used in the service (S2). Results Fifty patients with lupus nephritis (WHO classes III, IV and V), with a median age of 37years, were evaluated. Of these, 86.5% were female, and 52% were BILAG A. Podocyturia quantification in the lupus nephritis and control groups differed significantly (p = 0.009). This score was higher in relation to classes III, IV and V. The correlation with C3 consumption was stronger (p = 0.011) than with C4. The highest levels were found in the most active groups (A and B of BILAG and S2). Lower podocyturia correlated with a lower dose of prednisone. There was no association with the intensity of proteinuria, hematuria or pyuria, serum creatinine levels, among others. Conclusions Podocyturia assessment, which was performed by immunofluorescence in this study, can be used as an indicator of disease activity with the advantage of being a urinary biomarker. The levels proved to be higher in patients with lupus nephritis than in the controls and were particularly higher in class IV.Univ Fed Sao Paulo, UNIFESP, Div Nephrol, Napoleao de Barros St 715, BR-04024002 Sao Paulo, BrazilUniv Fed Sao Paulo, UNIFESP, Div Nephrol, Napoleao de Barros St 715, BR-04024002 Sao Paulo, BrazilWeb of ScienceBrazilian Council for Scientific and Technological Development (CNPq)Taylor & Francis Ltd2020-07-22T13:23:07Z2020-07-22T13:23:07Z2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion643-647http://dx.doi.org/10.3109/0886022X.2016.1150099Renal Failure. Abingdon, v. 38, n. 4, p. 643-647, 2016.10.3109/0886022X.2016.11500990886-022Xhttps://repositorio.unifesp.br/handle/11600/56047WOS:000372164000022engRenal FailureAbingdoninfo:eu-repo/semantics/openAccessMansur, Juliana Busato [UNIFESP]Sabino, Amelia Rodrigues Pereira [UNIFESP]Nishida, Sonia Kiyomi [UNIFESP]Kirsztajn, Gianna Mastroianni [UNIFESP]reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2021-10-04T21:26:15Zoai:repositorio.unifesp.br/:11600/56047Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652021-10-04T21:26:15Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Is there a role for urinary podocyte excretion assessment in lupus nephritis? |
title |
Is there a role for urinary podocyte excretion assessment in lupus nephritis? |
spellingShingle |
Is there a role for urinary podocyte excretion assessment in lupus nephritis? Mansur, Juliana Busato [UNIFESP] Glomerulonephritis systemic lupus erythematosus lupus nephritis podocyturia podocytes proteinuria |
title_short |
Is there a role for urinary podocyte excretion assessment in lupus nephritis? |
title_full |
Is there a role for urinary podocyte excretion assessment in lupus nephritis? |
title_fullStr |
Is there a role for urinary podocyte excretion assessment in lupus nephritis? |
title_full_unstemmed |
Is there a role for urinary podocyte excretion assessment in lupus nephritis? |
title_sort |
Is there a role for urinary podocyte excretion assessment in lupus nephritis? |
author |
Mansur, Juliana Busato [UNIFESP] |
author_facet |
Mansur, Juliana Busato [UNIFESP] Sabino, Amelia Rodrigues Pereira [UNIFESP] Nishida, Sonia Kiyomi [UNIFESP] Kirsztajn, Gianna Mastroianni [UNIFESP] |
author_role |
author |
author2 |
Sabino, Amelia Rodrigues Pereira [UNIFESP] Nishida, Sonia Kiyomi [UNIFESP] Kirsztajn, Gianna Mastroianni [UNIFESP] |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Mansur, Juliana Busato [UNIFESP] Sabino, Amelia Rodrigues Pereira [UNIFESP] Nishida, Sonia Kiyomi [UNIFESP] Kirsztajn, Gianna Mastroianni [UNIFESP] |
dc.subject.por.fl_str_mv |
Glomerulonephritis systemic lupus erythematosus lupus nephritis podocyturia podocytes proteinuria |
topic |
Glomerulonephritis systemic lupus erythematosus lupus nephritis podocyturia podocytes proteinuria |
description |
Objective To establish the occurrence and intensity of podocyturia and its relation to grade of disease activity, as defined by clinical and laboratory criteria. Methods Prospective, cross-sectional study involving 50 patients with lupus nephritis and 29 controls, which had podocyturia levels determined from random urine samples using an immunofluorescence technique. Disease activity was graded by BILAG (renal criteria) and an additional system used in the service (S2). Results Fifty patients with lupus nephritis (WHO classes III, IV and V), with a median age of 37years, were evaluated. Of these, 86.5% were female, and 52% were BILAG A. Podocyturia quantification in the lupus nephritis and control groups differed significantly (p = 0.009). This score was higher in relation to classes III, IV and V. The correlation with C3 consumption was stronger (p = 0.011) than with C4. The highest levels were found in the most active groups (A and B of BILAG and S2). Lower podocyturia correlated with a lower dose of prednisone. There was no association with the intensity of proteinuria, hematuria or pyuria, serum creatinine levels, among others. Conclusions Podocyturia assessment, which was performed by immunofluorescence in this study, can be used as an indicator of disease activity with the advantage of being a urinary biomarker. The levels proved to be higher in patients with lupus nephritis than in the controls and were particularly higher in class IV. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016 2020-07-22T13:23:07Z 2020-07-22T13:23:07Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.3109/0886022X.2016.1150099 Renal Failure. Abingdon, v. 38, n. 4, p. 643-647, 2016. 10.3109/0886022X.2016.1150099 0886-022X https://repositorio.unifesp.br/handle/11600/56047 WOS:000372164000022 |
url |
http://dx.doi.org/10.3109/0886022X.2016.1150099 https://repositorio.unifesp.br/handle/11600/56047 |
identifier_str_mv |
Renal Failure. Abingdon, v. 38, n. 4, p. 643-647, 2016. 10.3109/0886022X.2016.1150099 0886-022X WOS:000372164000022 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Renal Failure |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
643-647 |
dc.coverage.none.fl_str_mv |
Abingdon |
dc.publisher.none.fl_str_mv |
Taylor & Francis Ltd |
publisher.none.fl_str_mv |
Taylor & Francis Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268413670850560 |